Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema is a research paper published in Bioengineering (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 HL157626
National Institutes of Health
Grant: R03 HL154300
National Institutes of Health
Grant: K08HL132110
NCATS NIH HHS
Grant: KL2 TR001854
National Institutes of Health
Grant: 5R01HL157626-02
Retinoic Acid Induced Lymphangiogenesis for Post-surgical Lymphedema
National Institutes of Health
Grant: 5K08HL132110-04
Investigation of 9-cis Retinoic Acid as a Novel Treatment for Post-Surgical Lymphedema
National Institutes of Health
Grant: 7R03HL154300-02
Mitigation of lymphatic injury by retinoic acid therapyin a large animal model
FWCI
1.30
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals